Articles dans des revues avec comité de lecture (104)
1.
Dong, A., Vanuytven, S., Pérez González, A., Bévant, K., Van de Putte, L., Zahedi, Z., Allard, J., Dubois, C., Salmon, I., Rorive, S., & Blanpain, C. (2026). Myeloid-derived TGFβ1 and oncostatin M establish two distinct stromal niches controlling late and hybrid EMT states. Nature Cancer. doi:10.1038/s43018-026-01259-32.
Jiang, C., Song, Y., Rorive, S., Allard, J., Tika, E., Zahedi, Z., Dubois, C., Salmon, I., Sifrim, A., & Blanpain, C. (2025). Innate immunity and the NF-κB pathway control prostate stem cell plasticity, reprogramming and tumor initiation. Nature Cancer, 6(9), 1537-1558. doi:10.1038/s43018-025-00994-33.
Blanc, J., Carnot, A., Barthélémy, P., Casert, V., Sautois, B., Van den Brande, J., Vanhaudenarde, V., Staudacher, L., Seront, E., Debien, V., Ameye, L., Kotecki, N., Rothé, F., Rorive, S., Fantoni, J. C., Tricard, T., Roumeguère, T., Awada, A., & Martinez Chanza, N. (2025). Avelumab-based neoadjuvant therapy in patients with muscle-invasive bladder cancer (AURA Oncodistinct-004): a phase 2 multicenter clinical trial. Journal for ImmunoTherapy of Cancer, 13(5). doi:10.1136/jitc-2025-0120454.
Verocq, C., Noël, J. C., Charry, M., Zindy, E., Rorive, S., Salmon, I., Decaestecker, C., & Catteau, X. (2024). Inverse correlation between the amounts of lymphocytic infiltrate and stroma in breast carcinoma. Heliyon, 10(22), e40295. doi:10.1016/j.heliyon.2024.e402956.
Gleeson, P. J., Crippa, I. A., Sannier, A., Koopmansch, C., Bienfait, L., Allard, J., Sexton, D. D., Fontana, V., Rorive, S., Vincent, J. L., Creteur, J., & Taccone, F. S. (2023). Critically ill patients with acute kidney injury: clinical determinants and post-mortem histology. Clinical Kidney Journal, 16(10), 1664-1673. doi:10.1093/ckj/sfad1137.
Belhaj, A., Dewachter, L., Monier, A., Vegh, G., Rorive, S., Remmelink, M., Closset, M., Melot, C., Creteur, J., Salmon, I., & Rondelet, B. (2023). Beneficial Effects of Tacrolimus on Brain-Death-Associated Right Ventricular Dysfunction in Pigs. International Journal of Molecular Sciences (CD-ROM), 24(13), 10439. doi:10.3390/ijms2413104398.
Rusu, S., Remmelink, M., Van Eycken, M., Pletschette, Z., Bennouna, I., Fouarge, A., Trepant, A.-L., Salmon, I., Rorive, S., & Lebrun, L. (2022). Monomicrobial Necrotizing Fasciitis and Emphysematous Cystitis: Autopsy Report and Literature Review. Annals of Case Reports.9.
Belhaj, A., Dewachter, L., Hupkens, E., Remmelink, M., Galanti, L., Rorive, S., Melot, C., Naeije, R., & Rondelet, B. (2022). Tacrolimus Prevents Mechanical and Humoral Alterations in Brain Death-induced Lung Injury in Pigs. American journal of respiratory and critical care medicine, 206(5), 584-595. doi:10.1164/rccm.202201-0033OC10.
Rusu, S., Verocq, C., Trepant, A.-L., Maris, C., De Nève, N., Blanchard, O., Van Campenhout, C., De Clercq, S., Rorive, S., Cotoi, O. S., Decaestecker, C., Salmon, I., & D'Haene, N. (2021). Immunohistochemistry as an accurate tool for the assessment of BRAF V600E and TP53 mutations in primary and metastatic melanoma. Molecular and clinical oncology, 15(6), 270. doi:10.3892/mco.2021.243211.
Mauri, F., Schepkens, C., Lapouge, G., Drogat, B., Song, Y., Pastushenko, I., Rorive, S., Blondeau, J., Golstein, S., Bareche, Y., Miglianico, M., Nkusi, E., Rozzi, M., Moers, V., Brisebarre, A., Raphael, M., Dubois, C., Durdu, B., Ribeiro, F., Sotiriou, C., Salmon, I., Vakili, J., & Blanpain, C. (2021). NR2F2 controls malignant squamous cell carcinoma state by promoting stemness and invasion and repressing differentiation. Nature Cancer, 2(11), 1152-1169. doi:10.1038/s43018-021-00287-512.
Thouvenin, J., Colinet, V., Barthélémy, P., Sideris, S., Van Eycken, M., Rorive, S., Sirtaine, N., Hamid, A., Roumeguere, T., & Chanza, N. M. (2021). 624P Prevalence and clinical impact of PTEN status in patients (pts) with de novo metastatic hormone sensitive prostate cancer (mHSPC). Annals of oncology, 32, S661. doi:10.1016/j.annonc.2021.08.1137